ADAMTS5 as a therapeutic target for osteoarthritis: Mendelian randomisation study

Research output: Contribution to journal › Letter › peer-review

843 Downloads (Pure)

Original language	English
Pages (from-to)	annrheumdis-2021-222007
Journal	Annals of the rheumatic diseases
Early online date	7 Feb 2022
DOIs	https://doi.org/10.1136/annrheumdis-2021-222007
Publication status	Published - 7 Feb 2022

Access to Document

@article{d3e59f399fd3465b98a68d1d43c50e93,

title = "ADAMTS5 as a therapeutic target for osteoarthritis: Mendelian randomisation study",

author = "Zhao, {Sizheng Steven} and Ville Karhunen and Morris, {Andrew P} and Dipender Gill",

year = "2022",

month = feb,

day = "7",

doi = "10.1136/annrheumdis-2021-222007",

language = "English",

pages = "annrheumdis--2021--222007",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - ADAMTS5 as a therapeutic target for osteoarthritis: Mendelian randomisation study

AU - Zhao, Sizheng Steven

AU - Karhunen, Ville

AU - Morris, Andrew P

AU - Gill, Dipender

PY - 2022/2/7

Y1 - 2022/2/7

U2 - 10.1136/annrheumdis-2021-222007

DO - 10.1136/annrheumdis-2021-222007

M3 - Letter

SN - 0003-4967

SP - annrheumdis-2021-222007

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

ER -